News
20h
KTALnews.com on MSNGroup joins Sen. Cassidy to tour Dr. Reddy’s former lab for future economic developmentThe senator says he is all about economic development for North Louisiana and wants to build on assets. He says the facility ...
Dr. Reddy's Laboratories (NYSE:RDY) has denied reports that the company will be laying off its workforce to cut labor costs by 25%, calling it "factually incorrect." The Business Standard report ...
Pharmaceutical layoffs planned? No, says Dr Reddy's Laboratories, as the drugmaker categorically denied media reports that has undertaken workforce reduction to cut costs by around 25 per cent.
India's Dr Reddy's Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an ...
Dr Reddy’s Laboratories is yet to report its Q4 FY25 earnings as schedule for May 9. Analysts are expecting to see subtle margin improvement on a quarterly basis, with price erosion in the US ...
Shares of Dr. Reddy's Laboratories Ltd. 500124 rallied 2.23% to 1,199.70 Indian rupees Monday, on what proved to be an all-around positive trading session for the stock market, with the BSE SENSEX ...
Pharmaceutical major Dr Reddy's Laboratories has denied the news report by Business Standard claiming it is looking at a 25 percent workforce cost reduction, calling it 'factually incorrect', in ...
In this article, we will take a look at where Dr. Reddy’s Laboratories Limited (NYSE:RDY) stands against other best Indian stocks. India’s stock market had a rough ride during the second half ...
Pharma major Dr. Reddy’s Laboratories has on Monday said there was no reduction of 25 per cent workforce to bring down operational costs. Reacting to reports in a section of media, the Hyderabad ...
Pharma giant Dr Reddy’s Laboratories is reportedly cutting workforce-related costs by nearly 25%, signaling one of the most aggressive corporate restructurings in the Indian pharmaceutical ...
Chicago, IL – April 16, 2025 – Today, Zacks Equity Research Equity are Dr. Reddy’s Laboratories RDY, Sandoz SDZNY and Teva Pharmaceuticals TEVA. Industry: Generic Drugs Link: https://www ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results